MC Sciences

mcsciences.com

mcsciences.com • 51-200 employees • Likely startup • New

51-200 employees • Likely startup • New

Actively hiring

Overview

Salaries

Products

People

Growth

Offices

Financials

Funding and backers

Team

51-200

employees, estimated range

Backers

Canaan

Momentum

0/100

no fresh signals

Backed byfrom the funds' portfolios and accelerator catalogs

Canaan fund

Investors in similar startupsfunds that back the companies most like this one

Y Combinator

backs Relevium Medical

backs Alterome

backs Myollie

backs Myollie

backs ORIA Bioscience | Isolated Organelles for Drug Discovery

Nextech Invest

backs Alterome

Similar startupsby what they do, their industry and backers

Surf Therapeutics

Non-invasive, At-home Ultrasound Neuromodulation for Chronic Inflammatory Disorders.

ORIA Bioscience | Isolated Organelles for Drug DiscoveryFounded 2022

FROM CELLS TO ORGANELLES• ORGANELLES•. First-in-Class Isolated Organelles for Drug Discovery.

Greywolf TherapeuticsFounded 2017 • 501-1000 employees

Novel antigen modulation technology that controls T cells to guide the immune system.

Draig TherapeuticsFounded 2024 • 501-1000 employees

Transforming the Future of Neuropsychiatry. Draig Therapeutics is developing transformative, best-in-class neuropsychiatric therapies to…

Myollie1 role

Myollie is a healthcare technology company that develops and commercializes a suite of digital therapeutics for the treatment of chronic…

Alterome1 role

Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and…

Overview

FIRST-IN-CLASS SUPERIOR MAST CELL THERAPEUTICS. First-in-Class Superior Mast Cell Therapeutics targeting mast cells in major diseases areas with high need, across immunology, dermatology, respiratory, gastrointestinal and chronic inflammatory disorders.